The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and commercialization Is BPC 157 Banned? Oral vs. Injectable Forms Explained